Scientific papers - Collaborations (Movember GAP3 consortium)

1	Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure S.M. Bruinsma, M.J. Roobol, P.R. Carroll, L. Klotz, T. Pickles, C.M. Moore, V.J. Gnanapragasam, A. Villers, A. Rannikko, R. Valdagni, M. Frydenberg, Y. Kakehi, C.P. Filson, C.H. Bangma, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium Nature Reviews Urology 2017, 14 (5): 312-322 PubMed: 28290462
2	The Movember Foundation's GAP3 cohort: A profile of the largest global prostate cancer active surveillance database to date S.M. Bruinsma, L. Zhang, M.J. Roobol, C.H. Bangma, E.W. Steyerberg, D. Nieboer, M. Van Hemelrijck, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium BJU International 2018, 121 (5): 737-744 PubMed: 29247473
3	Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies T.H. van der Kwast, J. Helleman, D. Nieboer, S.M. Bruinsma, M.J. Roobol, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium European Urology Oncology 2019, 2 (3) PubMed: 31200849
4	Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium M. van Hemelrijck, X. Ji, J. Helleman, M.J. Roobol, W. van der Linden, D. Nieboer, C.H. Bangma, M. Frydenberg, A. Rannikko, L.S. Lee, V.J. Gnanapragasami, M.W. Kattan, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium European Urology 2019, 75 (3): 523-531 PubMed: 30385049
5	Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts F.-J. H. Drost, D. Nieboer, T.M. Morgan, P.R. Carroll, M.J. Roobol, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium European Urology 2019, 76 (5): 693-702 PubMed: 31451332
6	Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance Initiative A.A. Kalaparaa, J.F.M. Verbeek, D. Nieboer, M. Fahey, V. Gnanapragasam, M. Van Hemelrijck, L.S. Lee, C.H. Bangma, E.W. Steyerberg, T. Harkin, J. Helleman, M.J. Roobol, M. Frydenberg, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium European Urology Oncology 2020, 3 (1), 80-91 PubMed: 31564531
7	Personalized Biopsy Schedules Based on Risk of Gleason Upgrading for Low-Risk Prostate Cancer Active Surveillance Patients A. Tomer, D. Nieboer, M.J. Roobol, A. Bjartell, E.W. Steyerberg, D. Rizopoulos, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium BJU International 2021, 127: 96-107 PubMed: 32531869
8	Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies W. Li, B.T. Denton, D. Nieboer, M.J. Roobol, T.M. Morgan, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium Cancer Medicine 2021, 127: 96-107 PubMed: 33159431
9	Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative S.M. Bruinsma, D. Nieboer, M.J. Roobol, C.H. Bangma, J.F.M. Verbeek, V. Gnanapragasam, M. van Hemelrijck, M. Frydenberg, L.-S. Lee, R. Valdagni, C. Logothetis, E.W. Steyerberg, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium Journal of Urology 2021, 206 (1): 62-68 PubMed: 33617330
10	A first step towards a global nomogram to predict disease progression for men on active surveillance M. van Hemelrijck, X. Ji, J. Helleman, M.J. Roobol, D. Nieboer, C.H. Bangma, M. Frydenberg, A. Rannikko, L.S. Lee, V. Gnanapragasam, M.W. Kattan, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium Translational Andrology and Urology 2021, 10 (3): 1102-1109 PubMed: 33850745
11	Using the Movember Foundation’s GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function - a retrospective study in low-risk prostate cancer patients R.T. Crump, S. Remmers, M. van Hemelrijck, J. Helleman, D. Nieboer, M.J. Roobol, L.D.F. Venderbos, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium Translational Andrology and Urology 2021, 10 (6): 2719-2727 PubMed: 34295757
12	Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database K. Beckmann, A. Santaolalla, J. Helleman, P. Carroll, B.H. Chung, L.S. Lee, A. Perry, J. Rubio-Briones, M. Sugimoto, B. Trock, R. Valdagni, P. Dasgupta, M. Van Hemelrijck, O. Elhage, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium European Urology Open Science 2021, 34 (Suppl 1): 47-54 PubMed: 34934967
13	Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium J. Olivier, W. Li, D. Nieboer, J. Helleman, M.J. Roobol, V. Gnanapragasam, M. Frydenberg, M. Sugimoto, P. Carroll, T.M. Morgan, R. Valdagni, J. Rubio-Briones, G. Robert, P. Stricker, A. Hayen, I. Schoots, M. Haider, C.M. Moore, B. Denton, A. Villers, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium European Urology Open Science 2022, 35: 59–67 PubMed: 35024633
14	Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database K. Beckmann, C.H. Bangma, J. Helleman, A. Bjartell, P.R. Carroll, T. Morgan, D. Nieboer, A. Santaolalla, B.J. Trock, R. Valdagni, M.J. Roobol, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium Prostate 2022, 82 (7): 876-879 PubMed: 35254666
15	Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative S. Remmers, J. Helleman, D. Nieboer, B. Trock, M.E. Hyndman, C.M. Moore, V. Gnanapragasam, L.S. Lee, O. Elhage, L. Klotz, P. Carroll, T. Pickles, A. Bjartell, G. Robert, M. Frydenberg, M. Sugimoto, B. Ehdaie, T.M. Morgan, J. Rubio-Briones, A. Semjonow, C.H. Bangma, M.J. Roobol, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium European Urology Open Science 2022, 41: 126–133 PubMed: 35813247
16	Adverse Pathological Findings at Radical Prostatectomy following Active Surveillance: Results from the Movember GAP3 Cohort C. Marenghi, Z. Qiu, J. Helleman, D. Nieboer, J. Rubio-Briones, P.R. Carroll, L.S. Lee, R. Valdagni, P.C. Boutros, N. Nicolai, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium Cancers 2022, 14 (15): 3558 PubMed: 35892817
17	Risk of progression following a negative biopsy in prostate cancer active surveillance K. Beckmann, A. Santaolalla, M. Sugimoto, P. Carroll, J. Rubio, A. Villers, A. Bjartell, T. Morgan, P. Dasgupta, M. Van Hemelrijck, O. Elhage, Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium Prostate Cancer and Prostatic Diseases 2022, ?? (??): ?? PubMed: 36008540